#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4428	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2521	524.9	0	.	n	.	0	G1207A	SNP	1207	1207	G	1674	1674	A	665	A,G,C	575,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4428	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2521	524.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1917	1917	T	706	T,G	629,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4428	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2521	524.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1651	1651	C	692	C	592	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7078	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3772	562.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1788	1788	A	594	A,G,C	513,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7078	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3772	562.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2422	2422	C	667	C,T	581,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7078	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3772	562.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2496	2496	A	685	A	595	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7078	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3772	562.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3048	3048	C	599	C	521	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	586	folP	852	852	99.77	folP.l15.c4.ctg.1	1867	93.9	0	.	p	.	0	D71H	NONSYN	211	213	GAT	737	739	CAT	124;124;124	C;A;T	104;105;104	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	586	folP	852	852	99.77	folP.l15.c4.ctg.1	1867	93.9	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1136	1138	GTA	140;141;142	G;T;A	121;124;125	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	586	folP	852	852	99.77	folP.l15.c4.ctg.1	1867	93.9	1	SNP	p	R228S	0	.	.	682	684	CGC	1208	1210	CGC	154;155;156	C;G;C	133;135;135	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1230	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3642	101.1	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1135	1137	ATA	101;101;104	A,C;T;A	90,1;93;94	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1230	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3642	101.1	1	SNP	p	S91F	0	.	.	271	273	TCC	658	660	TCC	87;87;89	T;C;C	75;73;76	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1230	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3642	101.1	1	SNP	p	D95G	0	.	.	283	285	GAC	670	672	GAC	88;88;88	G;A;C	77;75;76	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1230	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3642	101.1	1	SNP	p	D95N	0	.	.	283	285	GAC	670	672	GAC	88;88;88	G;A;C	77;75;76	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	518	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1592	97.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	382	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1247	92.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1766	1768	GCA	143;142;141	G;C;A	127;126;124	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	1	SNP	p	D86N	0	.	.	256	258	GAC	719	721	GAC	177;175;175	G;A,C;C	150;148,1;149	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	1	SNP	p	S87W	0	.	.	259	261	AGT	722	724	AGT	173;173;173	A,C;G;T	143,1;152;148	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	1	SNP	p	S87I	0	.	.	259	261	AGT	722	724	AGT	173;173;173	A,C;G;T	143,1;152;148	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	1	SNP	p	S87R	0	.	.	259	261	AGT	722	724	AGT	173;173;173	A,C;G;T	143,1;152;148	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1258	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3248	116.4	1	SNP	p	S88P	0	.	.	262	264	TCC	725	727	TCC	173;173;173	T;C;C	145;149;148	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1116	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2856	117.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1663	1665	GGC	151;152;154	G;G;C	135;135;135	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1442	1444	GCA	164;165;167	G;C;A	145;147;149	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1445	1447	ATC	167;167;167	A;T;C	151;145;147	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1457	1459	GTG	169;169;170	G;T,G;G	152;145,1;148	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1457	1459	GTG	169;169;170	G;T,G;G	152;145,1;148	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1961	1963	ACC	163;163;162	A;C;C	149;147;147	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2015	2017	GCG	143;143;143	G;C;G	126;117;115	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2015	2017	GCG	143;143;143	G;C;G	126;117;115	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2138	2140	GGC	148;149;149	G;G;C	114;119;119	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2147	2149	GGC	149;149;150	G,A,C;G;C	110,1,1;116;123	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1116	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2767	121.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2165	2167	CCG	145;145;144	C;C;G	113;115;107	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1474	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3439	128.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1819	1821	CTG	139;140;139	C;T;G	115;116;120	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	692	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2215	93.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	797	797	C	130	C	115	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1222	1224	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1225	1227	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1237	1239	GTT	10;10;10	G;T;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1249	1251	GCA	10;10;10	G;C;A	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1272	1274	GTA	9;9;9	G;T;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	130	porB1a	984	178	90.11	porB1a.l15.c4.ctg.1	1375	27.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1281	1281	A	9	A	8	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	565	567	ATG	192;192;193	A;T;G	164;164;162	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	940	942	CAA	215;215;215	C;A;A	176;174;171	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1147	1149	GAT	210;210;211	G;A;T	186;189;189	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1150	1152	GGT	212;211;211	G;G;T	194;188;190	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1156	1158	GCT	211;211;211	G;C;T	184;189;192	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1171	1173	ACT	209;208;208	A;C;T,G	188;187;184,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1282	1284	ATG	224;225;227	A;T;G	190;190;192	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1285	1287	AGC	225;225;224	A;G;C	190;194;193	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1288	1290	GGT	225;225;225	G;G;T	193;195;194	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1402	1404	AAC	239;240;241	A;A;C	191;193;191	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	994	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1985	149.9	1	SNP	p	G120K	0	.	.	358	360	GGC	871	873	GGC	215;216;216	G;G,A;C	184;184,1;187	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3214	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5136	187.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2133	2135	CAT	206;206;207	C;A,C;T	179;175,1;181	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	434	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1366	95.4	1	SNP	p	V57M	0	.	.	169	171	GTG	684	686	GTG	182;180;180	G,A;T;G,T	147,1;149;145,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
